FFAR4 and prostate carcinoma: In prostate cancer, the fatty acid omega-3 inhibits tumour invasion by inhibiting angiogenesis and the T-cell inhibition induced by M2 macrophages, which further highlights the therapeutic potential of host G protein-coupled receptor 120 (GPR120)-dependent omega-3 fatty acids in inhibiting M2 macrophages in prostate cancer [99].